SFDA Pioneers Global Approval for ZENBEXUS in Treating Multiple Myeloma
Riyadh: The Saudi Food and Drug Authority (SFDA) has approved the registration of ZENBEXUS (iberdomide) for the treatment of adult patients with relapsed or refractory multiple myeloma in combination with daratumumab and dexamethasone. The SFDA is the…